Maelstrom Research Staging | StopCoV_30-50year_olds

StopCoV_30-50year_olds_eDiary

Networks -

Variables -

Associated study StopCoV Contingency Table

Population

StopCoV - 30-50 year olds

The population is composed of individuals between the ages of 30 and 50 years old that will receive or have received a first or second dose of a COVID-19 vaccine at an Ontario vaccine distribution center.

Selection Criteria

Minimum age

Maximum age

Newborns

Twins

Countries

Canada

Territory

Ethnic Origin

Health Status

Other Criteria

Inclusion: Individuals who can speak, read and understand English (or have a trusted individual to help with study procedures).
Exclusion:

Individuals who are less than 30 years or those 51-69 years.

Those who are unable to complete the study protocols in English either alone or with the assistance of a trusted individual with an electronic device.

Participants who enroll but do not receive any dose of the vaccine.

Recruitment

Sources of recruitment

General population

General Population

Volunteer enrolment

Supplementary Information

A random sample of emails of persons registering for vaccination at an Ontario center who provide their email and consent to be contacted for research in the target population age groups will be forwarded by the Ministry of Ontario to the study site. The study site in turn will forward the email blast electronically to the participants on the list directing them to the STOPCoV study website. Pamphlets and posters describing the study and providing the website and contact information will be made available at Toronto vaccine distribution centers, primary care offices, pharmacies and community organizations supporting vaccine uptake.

Number of Participants

Number of Participants: 400
Number of Participants with Biological Samples

More info

Data Collection Event

StopCoV - 30-50 year olds - eDiary

Information was collected through an electronic diary to record the date of their vaccination (or any changes) and any booster and to respond to questions about potential adverse events including local reactions (induration, itch, pain, redness, swelling, tenderness) and systemic reactions (chills, fever, headache, myalgias, malaise, arthralgias, nausea) for the 7-day period after each vaccine dose or booster.

More info

Collected Dataset / StopCoV_30-50year_olds_eDiary

StopCoV_30-50year_olds_eDiary

Population

StopCoV - 30-50 year olds

Data Collection Event

StopCoV - 30-50 year olds - eDiary

Files

Variables Classifications